prehospital cardiac arrest
Recently Published Documents


TOTAL DOCUMENTS

157
(FIVE YEARS 11)

H-INDEX

28
(FIVE YEARS 1)

2022 ◽  
Vol 26 (sup1) ◽  
pp. 54-63
Author(s):  
Jestin N. Carlson ◽  
M. Riccardo Colella ◽  
Mohamud R. Daya ◽  
Valerie J. De Maio ◽  
Philip Nawrocki ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Mathias Fabre ◽  
Christophe A. Fehlmann ◽  
Kevin E. Boczar ◽  
Birgit Gartner ◽  
Catherine G. Zimmermann-Ivol ◽  
...  

Abstract Background Acute Heart Failure (AHF) is a potentially lethal pathology and is often encountered in the prehospital setting. Although an association between prehospital arterial hypercapnia in AHF patients and admission in high-dependency and intensive care units has been previously described, there is little data to support an association between prehospital arterial hypercapnia and mortality in this population. Methods This was a retrospective study based on electronically recorded prehospital medical files. All adult patients with AHF were included. Records lacking arterial blood gas data were excluded. Other exclusion criteria included the presence of a potentially confounding diagnosis, prehospital cardiac arrest, and inter-hospital transfers. Hypercapnia was defined as a PaCO2 higher than 6.0 kPa. The primary outcome was in-hospital mortality, and secondary outcomes were 7-day mortality and emergency room length of stay (ER LOS). Univariable and multivariable logistic regression models were used. Results We included 225 patients in the analysis. Prehospital hypercapnia was found in 132 (58.7%) patients. In-hospital mortality was higher in patients with hypercapnia (17.4% [23/132] versus 6.5% [6/93], p = 0.016), with a crude odds-ratio of 3.06 (95%CI 1.19–7.85). After adjustment for pre-specified covariates, the adjusted OR was 3.18 (95%CI 1.22–8.26). The overall 7-day mortality was also higher in hypercapnic patients (13.6% versus 5.5%, p = 0.044), and ER LOS was shorter in this population (5.6 h versus 7.1 h, p = 0.018). Conclusion Prehospital hypercapnia is associated with an increase in in-hospital and 7-day mortality in patient with AHF.


2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Hjalti Mar Bjornsson ◽  
Gudrun G. Bjornsdottir ◽  
Hronn Olafsdottir ◽  
Brynjolfur Arni Mogensen ◽  
Brynjolfur Mogensen ◽  
...  

2020 ◽  
pp. 1-7
Author(s):  
Dustin Rowland ◽  
Nicholas Vryhof ◽  
David Overton ◽  
Joshua Mastenbrook

2020 ◽  
Vol 58 (2) ◽  
pp. 254-259
Author(s):  
John Teefy ◽  
Natalie Cram ◽  
Theunis Van Zyl ◽  
Kristine Van Aarsen ◽  
Shelley McLeod ◽  
...  

2020 ◽  
pp. 3626-3655
Author(s):  
Rajesh K. Kharbanda ◽  
Keith A.A. Fox

Acute coronary syndrome (ACS) is precipitated by an abrupt change in an atheromatous plaque and/or thrombotic occlusion. This results in increased obstruction to perfusion and ischaemia or infarction in the territory supplied by the affected vessel. The clinical consequences of plaque rupture can range from a clinically silent episode, through to unstable symptoms of ischaemia without infarction, to profound ischaemia complicated by progressive infarction, heart failure, arrhythmia, and risk of sudden death. Clinical presentation with an ACS identifies a patient at high risk of further cardiovascular events requiring a defined acute and long-term management strategy. Prompt relief of pain is important, not only for humanitarian reasons, but also because pain is associated with sympathetic activation, vasoconstriction, and increased myocardial work. The management of prehospital cardiac arrest requires special attention: at least as many lives can be saved by prompt resuscitation and defibrillation as by reperfusion.


Sign in / Sign up

Export Citation Format

Share Document